

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 8.35411545 |
| 2 | negative regulation of glucose import (GO:0046325) | 7.80786260 |
| 3 | protein activation cascade (GO:0072376) | 7.60660018 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.49788586 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.21420171 |
| 6 | negative regulation of glucose transport (GO:0010829) | 6.08761618 |
| 7 | humoral immune response (GO:0006959) | 6.04704838 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.02179012 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.02179012 |
| 10 | T cell migration (GO:0072678) | 5.77289400 |
| 11 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.68858198 |
| 12 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.68858198 |
| 13 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.68858198 |
| 14 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.65053406 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.29719254 |
| 16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.21628010 |
| 17 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.92651022 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 4.85895803 |
| 19 | negative regulation of B cell proliferation (GO:0030889) | 4.85372825 |
| 20 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.84296710 |
| 21 | apoptotic cell clearance (GO:0043277) | 4.82212688 |
| 22 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.76148447 |
| 23 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.69921462 |
| 24 | L-fucose catabolic process (GO:0042355) | 4.64911626 |
| 25 | fucose catabolic process (GO:0019317) | 4.64911626 |
| 26 | L-fucose metabolic process (GO:0042354) | 4.64911626 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.64883803 |
| 28 | B cell homeostasis (GO:0001782) | 4.55636896 |
| 29 | retina homeostasis (GO:0001895) | 4.41050233 |
| 30 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.40885812 |
| 31 | exocrine pancreas development (GO:0031017) | 4.39591350 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 4.35534620 |
| 33 | negative thymic T cell selection (GO:0045060) | 4.22663152 |
| 34 | cytidine metabolic process (GO:0046087) | 4.04621944 |
| 35 | cytidine catabolic process (GO:0006216) | 4.04621944 |
| 36 | cytidine deamination (GO:0009972) | 4.04621944 |
| 37 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.01485340 |
| 38 | intestinal epithelial cell development (GO:0060576) | 4.00194409 |
| 39 | negative T cell selection (GO:0043383) | 3.96100910 |
| 40 | vitamin transmembrane transport (GO:0035461) | 3.93503274 |
| 41 | cellular response to antibiotic (GO:0071236) | 3.85859297 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.83675358 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.83675358 |
| 44 | T cell lineage commitment (GO:0002360) | 3.81342232 |
| 45 | response to type I interferon (GO:0034340) | 3.79449481 |
| 46 | purine nucleobase biosynthetic process (GO:0009113) | 3.78876198 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.76387735 |
| 48 | B cell mediated immunity (GO:0019724) | 3.75850209 |
| 49 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.74604799 |
| 50 | peptidyl-asparagine modification (GO:0018196) | 3.68864380 |
| 51 | regulation of B cell proliferation (GO:0030888) | 3.68487774 |
| 52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.64153287 |
| 53 | amino sugar catabolic process (GO:0046348) | 3.61129763 |
| 54 | respiratory burst (GO:0045730) | 3.56243027 |
| 55 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.52092055 |
| 56 | B cell proliferation (GO:0042100) | 3.47932218 |
| 57 | mature B cell differentiation involved in immune response (GO:0002313) | 3.47455113 |
| 58 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.44431807 |
| 59 | folic acid transport (GO:0015884) | 3.44043606 |
| 60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43867512 |
| 61 | myeloid dendritic cell differentiation (GO:0043011) | 3.43680050 |
| 62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.42182437 |
| 63 | protein N-linked glycosylation (GO:0006487) | 3.40734488 |
| 64 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.36273255 |
| 65 | myeloid dendritic cell activation (GO:0001773) | 3.36228073 |
| 66 | cellular response to unfolded protein (GO:0034620) | 3.33680133 |
| 67 | mannose metabolic process (GO:0006013) | 3.32531213 |
| 68 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.26891140 |
| 69 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.24578107 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.23354407 |
| 71 | L-methionine salvage (GO:0071267) | 3.22677789 |
| 72 | L-methionine biosynthetic process (GO:0071265) | 3.22677789 |
| 73 | amino acid salvage (GO:0043102) | 3.22677789 |
| 74 | positive regulation of protein homooligomerization (GO:0032464) | 3.21179565 |
| 75 | thymic T cell selection (GO:0045061) | 3.18504353 |
| 76 | cellular response to topologically incorrect protein (GO:0035967) | 3.18071075 |
| 77 | defense response to protozoan (GO:0042832) | 3.17660880 |
| 78 | nucleobase biosynthetic process (GO:0046112) | 3.16748952 |
| 79 | positive regulation of nuclease activity (GO:0032075) | 3.15889425 |
| 80 | response to endoplasmic reticulum stress (GO:0034976) | 3.14840243 |
| 81 | DNA deamination (GO:0045006) | 3.13915102 |
| 82 | mature B cell differentiation (GO:0002335) | 3.13025139 |
| 83 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.12593047 |
| 84 | lymphocyte migration (GO:0072676) | 3.11469131 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08310048 |
| 86 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 3.07807954 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07264059 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07046042 |
| 89 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.06787647 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05333725 |
| 91 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.05247272 |
| 92 | regulation of nuclease activity (GO:0032069) | 3.04996195 |
| 93 | nucleosome assembly (GO:0006334) | 3.01704311 |
| 94 | negative regulation of osteoclast differentiation (GO:0045671) | 3.00271743 |
| 95 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.99798506 |
| 96 | L-serine metabolic process (GO:0006563) | 2.98639148 |
| 97 | N-acetylneuraminate metabolic process (GO:0006054) | 2.98431821 |
| 98 | lymphocyte homeostasis (GO:0002260) | 2.98018090 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.96713382 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.96713382 |
| 101 | modulation by symbiont of host immune response (GO:0052553) | 2.96713382 |
| 102 | positive regulation by symbiont of host defense response (GO:0052509) | 2.96713382 |
| 103 | modulation by symbiont of host defense response (GO:0052031) | 2.96713382 |
| 104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.96713382 |
| 105 | negative regulation of cell killing (GO:0031342) | 2.95829640 |
| 106 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95829640 |
| 107 | positive regulation of immunoglobulin production (GO:0002639) | 2.94650484 |
| 108 | antimicrobial humoral response (GO:0019730) | 2.94528917 |
| 109 | antibacterial humoral response (GO:0019731) | 2.94224793 |
| 110 | positive regulation of interleukin-2 production (GO:0032743) | 2.93984977 |
| 111 | regulation of translation in response to stress (GO:0043555) | 2.93963091 |
| 112 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.93012025 |
| 113 | termination of RNA polymerase III transcription (GO:0006386) | 2.93012025 |
| 114 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.91325922 |
| 115 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.91325922 |
| 116 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.90771834 |
| 117 | ER-nucleus signaling pathway (GO:0006984) | 2.90493911 |
| 118 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.89908715 |
| 119 | response to protozoan (GO:0001562) | 2.89793812 |
| 120 | positive regulation of protein oligomerization (GO:0032461) | 2.89713543 |
| 121 | positive regulation of Rap GTPase activity (GO:0032854) | 2.88801428 |
| 122 | T cell costimulation (GO:0031295) | 2.88133439 |
| 123 | cofactor transport (GO:0051181) | 2.87977217 |
| 124 | tongue development (GO:0043586) | 2.87446569 |
| 125 | cellular response to interferon-gamma (GO:0071346) | 2.87027252 |
| 126 | mesoderm development (GO:0007498) | 2.86898173 |
| 127 | ribosome assembly (GO:0042255) | 2.85815866 |
| 128 | regulation of protein heterodimerization activity (GO:0043497) | 2.84409718 |
| 129 | lymphocyte costimulation (GO:0031294) | 2.84172271 |
| 130 | regulation of B cell differentiation (GO:0045577) | 2.84152456 |
| 131 | cellular response to toxic substance (GO:0097237) | 2.83982520 |
| 132 | defense response to Gram-negative bacterium (GO:0050829) | 2.83378140 |
| 133 | positive thymic T cell selection (GO:0045059) | 2.83282653 |
| 134 | positive regulation of interferon-alpha production (GO:0032727) | 2.82496734 |
| 135 | regulation of defense response to virus by host (GO:0050691) | 2.81389887 |
| 136 | positive regulation of chromosome segregation (GO:0051984) | 2.79003766 |
| 137 | B cell receptor signaling pathway (GO:0050853) | 2.77978130 |
| 138 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.77971983 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.77407659 |
| 140 | epithelial cell maturation (GO:0002070) | 2.76445635 |
| 141 | maturation of SSU-rRNA (GO:0030490) | 2.75611370 |
| 142 | peptidyl-arginine methylation (GO:0018216) | 2.73904194 |
| 143 | peptidyl-arginine N-methylation (GO:0035246) | 2.73904194 |
| 144 | T cell selection (GO:0045058) | 2.73570659 |
| 145 | positive regulation of humoral immune response (GO:0002922) | 2.72956543 |
| 146 | ribosome biogenesis (GO:0042254) | 2.70229936 |
| 147 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.69742851 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.69651227 |
| 149 | cellular response to interferon-beta (GO:0035458) | 2.67568898 |
| 150 | blastocyst development (GO:0001824) | 2.67372874 |
| 151 | organ or tissue specific immune response (GO:0002251) | 2.66804082 |
| 152 | protein-DNA complex assembly (GO:0065004) | 2.64683169 |
| 153 | regulation of B cell apoptotic process (GO:0002902) | 2.64284588 |
| 154 | negative regulation of bone resorption (GO:0045779) | 2.64205544 |
| 155 | regulation of interferon-alpha production (GO:0032647) | 2.63423683 |
| 156 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.61943638 |
| 157 | regulation of B cell activation (GO:0050864) | 2.60231307 |
| 158 | immune response-activating signal transduction (GO:0002757) | 2.59357556 |
| 159 | positive regulation of B cell proliferation (GO:0030890) | 2.58574689 |
| 160 | cell redox homeostasis (GO:0045454) | 2.58408938 |
| 161 | mitotic metaphase plate congression (GO:0007080) | 2.58313217 |
| 162 | GDP-mannose metabolic process (GO:0019673) | 2.58088712 |
| 163 | rRNA modification (GO:0000154) | 2.57920843 |
| 164 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.56943915 |
| 165 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.56785781 |
| 166 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.55279575 |
| 167 | positive regulation of B cell activation (GO:0050871) | 2.53299512 |
| 168 | negative regulation of viral genome replication (GO:0045071) | 2.51066032 |
| 169 | response to interferon-beta (GO:0035456) | 2.50757293 |
| 170 | T-helper 1 type immune response (GO:0042088) | 2.50370993 |
| 171 | positive regulation of defense response to virus by host (GO:0002230) | 2.49925549 |
| 172 | response to interferon-gamma (GO:0034341) | 2.49594219 |
| 173 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.48970162 |
| 174 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.47579004 |
| 175 | positive regulation of B cell mediated immunity (GO:0002714) | 2.47579004 |
| 176 | ribosomal small subunit biogenesis (GO:0042274) | 2.46417962 |
| 177 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44508180 |
| 178 | gonadal mesoderm development (GO:0007506) | 19.7803105 |
| 179 | complement activation, classical pathway (GO:0006958) | 15.1738890 |
| 180 | complement activation (GO:0006956) | 11.7139400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55870695 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.07584144 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.51727926 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41341897 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.34029452 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.23645397 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.93713203 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85223574 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.84793790 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.81797052 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.80753352 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53328203 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53065511 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.48586991 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46961960 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.46449907 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.42966044 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.36676365 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29792137 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28906403 |
| 21 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.13595296 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09605909 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.07548957 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.03861007 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97721739 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97622068 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96151897 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94393049 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.93475291 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89405235 |
| 31 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.84088478 |
| 32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.78824047 |
| 33 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.73359767 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72863297 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72509795 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72340242 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.71553803 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70003242 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68333391 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.67710899 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66568307 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65477118 |
| 43 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.62315242 |
| 44 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57299591 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54503517 |
| 46 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.50383372 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.50137339 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49705570 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48717526 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.45187655 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44576197 |
| 52 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41504447 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40785849 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.39806030 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37597785 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36849003 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36282281 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35251801 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.33695333 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33528841 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.31846644 |
| 62 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31818006 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31461155 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31385113 |
| 65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31118561 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29816893 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29236438 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28666886 |
| 69 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28108621 |
| 70 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26025076 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25735968 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.24403183 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24380889 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22919651 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20810897 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20549702 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19543034 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19139335 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16917269 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16392373 |
| 81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15437337 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14219338 |
| 83 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13840172 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13511996 |
| 85 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13352814 |
| 86 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13295113 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13073984 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12314467 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11661518 |
| 90 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11120032 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11013079 |
| 92 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.10936356 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10170058 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09419553 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09112219 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08498559 |
| 97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07864320 |
| 98 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05222485 |
| 99 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.04777470 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04683176 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03542703 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02296863 |
| 103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01449805 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01326667 |
| 105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00780363 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99118095 |
| 107 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98772454 |
| 108 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98772454 |
| 109 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98772454 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98014629 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97506855 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97427961 |
| 113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96696841 |
| 114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95877465 |
| 115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95818812 |
| 116 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95340746 |
| 117 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94952694 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94523721 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94094319 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93462259 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93053409 |
| 122 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.91963019 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91816871 |
| 124 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90994505 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90480559 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89732982 |
| 127 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.89315026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.07308308 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.09855791 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 3.94232060 |
| 4 | MP0005671_abnormal_response_to | 3.85369189 |
| 5 | MP0009840_abnormal_foam_cell | 3.71517983 |
| 6 | MP0001800_abnormal_humoral_immune | 3.30976054 |
| 7 | MP0006082_CNS_inflammation | 2.88499794 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.87607339 |
| 9 | MP0008260_abnormal_autophagy | 2.79849583 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.69055039 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.65831801 |
| 12 | MP0005387_immune_system_phenotype | 2.62346040 |
| 13 | MP0001790_abnormal_immune_system | 2.62346040 |
| 14 | MP0005310_abnormal_salivary_gland | 2.60644357 |
| 15 | MP0003303_peritoneal_inflammation | 2.56694541 |
| 16 | MP0001348_abnormal_lacrimal_gland | 2.42884685 |
| 17 | MP0002723_abnormal_immune_serum | 2.41033713 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.36213675 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.34661415 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.26876317 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.21969735 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.13479711 |
| 23 | MP0001819_abnormal_immune_cell | 2.13004398 |
| 24 | MP0005025_abnormal_response_to | 2.12193552 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 2.07293084 |
| 26 | MP0000685_abnormal_immune_system | 1.95870587 |
| 27 | MP0002419_abnormal_innate_immunity | 1.94969366 |
| 28 | MP0002163_abnormal_gland_morphology | 1.87748451 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.82592786 |
| 30 | MP0002398_abnormal_bone_marrow | 1.81574375 |
| 31 | * MP0000716_abnormal_immune_system | 1.79953847 |
| 32 | MP0008057_abnormal_DNA_replication | 1.76234819 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.69650609 |
| 34 | MP0003436_decreased_susceptibility_to | 1.68273584 |
| 35 | MP0001542_abnormal_bone_strength | 1.68064843 |
| 36 | MP0003195_calcinosis | 1.56107498 |
| 37 | MP0001661_extended_life_span | 1.54941446 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.53626757 |
| 39 | * MP0002429_abnormal_blood_cell | 1.53452335 |
| 40 | MP0002722_abnormal_immune_system | 1.51748508 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.45718609 |
| 42 | MP0003879_abnormal_hair_cell | 1.45621173 |
| 43 | MP0002254_reproductive_system_inflammat | 1.45422400 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.42203784 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.39277976 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.37958695 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.36956892 |
| 48 | MP0005451_abnormal_body_composition | 1.34372518 |
| 49 | MP0003045_fibrosis | 1.33442276 |
| 50 | MP0001853_heart_inflammation | 1.28742698 |
| 51 | MP0009785_altered_susceptibility_to | 1.26852566 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.26396148 |
| 53 | MP0003878_abnormal_ear_physiology | 1.24759330 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.24759330 |
| 55 | MP0004947_skin_inflammation | 1.22862954 |
| 56 | MP0003718_maternal_effect | 1.20360195 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.18675061 |
| 58 | MP0000490_abnormal_crypts_of | 1.18276616 |
| 59 | MP0002006_tumorigenesis | 1.18194794 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.16955838 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.15837576 |
| 62 | MP0003075_altered_response_to | 1.14459819 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.14258264 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.14258264 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 1.13157736 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.12141925 |
| 67 | MP0008469_abnormal_protein_level | 1.08147190 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 1.05661029 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.04519404 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 1.02418657 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.02079945 |
| 72 | MP0003828_pulmonary_edema | 1.01592259 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.01519003 |
| 74 | MP0004043_abnormal_pH_regulation | 1.00896234 |
| 75 | MP0000609_abnormal_liver_physiology | 1.00856770 |
| 76 | MP0003077_abnormal_cell_cycle | 1.00362609 |
| 77 | MP0002405_respiratory_system_inflammati | 0.99280610 |
| 78 | MP0004510_myositis | 0.97844750 |
| 79 | MP0001663_abnormal_digestive_system | 0.94025741 |
| 80 | MP0003690_abnormal_glial_cell | 0.93936699 |
| 81 | MP0002933_joint_inflammation | 0.88689375 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.88664793 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.88324440 |
| 84 | MP0008007_abnormal_cellular_replicative | 0.87699104 |
| 85 | MP0010094_abnormal_chromosome_stability | 0.84385715 |
| 86 | MP0002928_abnormal_bile_duct | 0.84293475 |
| 87 | MP0001873_stomach_inflammation | 0.84032653 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.83653778 |
| 89 | MP0002132_abnormal_respiratory_system | 0.82390587 |
| 90 | MP0003186_abnormal_redox_activity | 0.81077226 |
| 91 | MP0003252_abnormal_bile_duct | 0.79968283 |
| 92 | MP0000858_altered_metastatic_potential | 0.79966644 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.77044239 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.77004450 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.76241805 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.75215317 |
| 97 | MP0010307_abnormal_tumor_latency | 0.75082291 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.73913495 |
| 99 | MP0002168_other_aberrant_phenotype | 0.70888067 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.70708247 |
| 101 | MP0003724_increased_susceptibility_to | 0.68847157 |
| 102 | MP0008872_abnormal_physiological_respon | 0.68371186 |
| 103 | MP0003866_abnormal_defecation | 0.67228916 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.65489592 |
| 105 | MP0003786_premature_aging | 0.65155123 |
| 106 | MP0005395_other_phenotype | 0.63470742 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.62565521 |
| 108 | MP0005332_abnormal_amino_acid | 0.61931976 |
| 109 | MP0008058_abnormal_DNA_repair | 0.61833022 |
| 110 | MP0005499_abnormal_olfactory_system | 0.60954844 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.60954844 |
| 112 | MP0005389_reproductive_system_phenotype | 0.60193656 |
| 113 | MP0001919_abnormal_reproductive_system | 0.59995076 |
| 114 | MP0002083_premature_death | 0.59925683 |
| 115 | MP0001191_abnormal_skin_condition | 0.59750610 |
| 116 | MP0000747_muscle_weakness | 0.59398543 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.59381424 |
| 118 | MP0008995_early_reproductive_senescence | 0.57881612 |
| 119 | MP0001346_abnormal_lacrimal_gland | 0.57449500 |
| 120 | MP0003123_paternal_imprinting | 0.57349616 |
| 121 | MP0001764_abnormal_homeostasis | 0.57256602 |
| 122 | MP0000371_diluted_coat_color | 0.56064813 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.55978245 |
| 124 | MP0003868_abnormal_feces_composition | 0.53118719 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.53046388 |
| 126 | MP0000313_abnormal_cell_death | 0.53026168 |
| 127 | MP0001944_abnormal_pancreas_morphology | 0.52668337 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.52341465 |
| 129 | MP0002009_preneoplasia | 0.51941980 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.51784701 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.51776251 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49859684 |
| 133 | MP0008874_decreased_physiological_sensi | 0.46635361 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.45377549 |
| 135 | MP0004142_abnormal_muscle_tone | 0.45343492 |
| 136 | MP0001986_abnormal_taste_sensitivity | 0.44049069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 7.17217851 |
| 2 | Abnormality of B cell number (HP:0010975) | 7.17217851 |
| 3 | Agammaglobulinemia (HP:0004432) | 6.68586498 |
| 4 | Colitis (HP:0002583) | 6.21382353 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.95011021 |
| 6 | Recurrent sinusitis (HP:0011108) | 4.83312514 |
| 7 | Conical tooth (HP:0000698) | 4.69105003 |
| 8 | Cellulitis (HP:0100658) | 4.60083410 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.50130857 |
| 10 | Recurrent pneumonia (HP:0006532) | 4.42137378 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.34975470 |
| 12 | Chronic otitis media (HP:0000389) | 4.31605380 |
| 13 | Inflammation of the large intestine (HP:0002037) | 4.30783390 |
| 14 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.27195886 |
| 15 | Lymphopenia (HP:0001888) | 4.23008512 |
| 16 | IgM deficiency (HP:0002850) | 4.22348306 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.13176364 |
| 18 | Recurrent viral infections (HP:0004429) | 3.95116470 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.93774697 |
| 20 | Dry hair (HP:0011359) | 3.88266116 |
| 21 | Onycholysis (HP:0001806) | 3.86344570 |
| 22 | Vasculitis (HP:0002633) | 3.82236064 |
| 23 | Pustule (HP:0200039) | 3.69254416 |
| 24 | Erythema (HP:0010783) | 3.58329281 |
| 25 | Meningitis (HP:0001287) | 3.51240849 |
| 26 | Glomerulonephritis (HP:0000099) | 3.48331762 |
| 27 | Verrucae (HP:0200043) | 3.42049023 |
| 28 | Papilloma (HP:0012740) | 3.42049023 |
| 29 | Chronic sinusitis (HP:0011109) | 3.36730168 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36290159 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 3.32831320 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.28956585 |
| 33 | Myositis (HP:0100614) | 3.24955723 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23129906 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23129906 |
| 36 | Recurrent lower respiratory tract infections (HP:0002783) | 3.16091751 |
| 37 | Abnormality of alanine metabolism (HP:0010916) | 3.11879821 |
| 38 | Hyperalaninemia (HP:0003348) | 3.11879821 |
| 39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.11879821 |
| 40 | Osteomyelitis (HP:0002754) | 3.05232006 |
| 41 | Recurrent abscess formation (HP:0002722) | 3.03754498 |
| 42 | Abnormality of T cells (HP:0002843) | 3.02728749 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99745794 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99745794 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99745794 |
| 46 | Chronic diarrhea (HP:0002028) | 2.95382527 |
| 47 | Increased IgM level (HP:0003496) | 2.90716472 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.89338664 |
| 49 | Lymphoma (HP:0002665) | 2.88517782 |
| 50 | Restrictive lung disease (HP:0002091) | 2.78448969 |
| 51 | Mutism (HP:0002300) | 2.76603873 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.74641037 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.71783692 |
| 54 | Ridged nail (HP:0001807) | 2.71723843 |
| 55 | Recurrent otitis media (HP:0000403) | 2.71273747 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.70161982 |
| 57 | Premature loss of primary teeth (HP:0006323) | 2.67924258 |
| 58 | Skin rash (HP:0000988) | 2.65365782 |
| 59 | Birth length less than 3rd percentile (HP:0003561) | 2.60160710 |
| 60 | Squamous cell carcinoma (HP:0002860) | 2.57779675 |
| 61 | Bronchitis (HP:0012387) | 2.57030026 |
| 62 | Acute hepatic failure (HP:0006554) | 2.56211644 |
| 63 | Abnormality of the prostate (HP:0008775) | 2.56031211 |
| 64 | Seborrheic dermatitis (HP:0001051) | 2.55702430 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.51427117 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.51058566 |
| 67 | Leukopenia (HP:0001882) | 2.45046012 |
| 68 | Rough bone trabeculation (HP:0100670) | 2.44855336 |
| 69 | Complement deficiency (HP:0004431) | 2.43728960 |
| 70 | Hyperglycinemia (HP:0002154) | 2.42458660 |
| 71 | Abnormality of incisor morphology (HP:0011063) | 2.41363108 |
| 72 | Viral hepatitis (HP:0006562) | 2.39414188 |
| 73 | Abnormality of the umbilical cord (HP:0010881) | 2.38896981 |
| 74 | Blepharitis (HP:0000498) | 2.37007507 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.30372785 |
| 76 | Hyperactive renin-angiotensin system (HP:0000841) | 2.29531600 |
| 77 | IgG deficiency (HP:0004315) | 2.23682040 |
| 78 | Cerebral hypomyelination (HP:0006808) | 2.23498111 |
| 79 | Eczematoid dermatitis (HP:0000976) | 2.23312679 |
| 80 | Petechiae (HP:0000967) | 2.22999406 |
| 81 | Retrobulbar optic neuritis (HP:0100654) | 2.22633061 |
| 82 | Optic neuritis (HP:0100653) | 2.22633061 |
| 83 | Hypokalemic alkalosis (HP:0001949) | 2.22368779 |
| 84 | Emphysema (HP:0002097) | 2.20594643 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.16959550 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16959550 |
| 87 | Personality changes (HP:0000751) | 2.16579224 |
| 88 | Carpal bone hypoplasia (HP:0001498) | 2.16540380 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 2.13938312 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 2.08014313 |
| 91 | Disinhibition (HP:0000734) | 2.06599084 |
| 92 | Myocardial infarction (HP:0001658) | 2.05937662 |
| 93 | Neutropenia (HP:0001875) | 2.03756692 |
| 94 | Basal cell carcinoma (HP:0002671) | 2.03266957 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 2.02635893 |
| 96 | Albinism (HP:0001022) | 2.02599402 |
| 97 | Increased IgE level (HP:0003212) | 2.02317778 |
| 98 | Type 2 muscle fiber atrophy (HP:0003554) | 2.01884118 |
| 99 | Bronchiectasis (HP:0002110) | 2.01573496 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 2.01134969 |
| 101 | Sepsis (HP:0100806) | 2.00023779 |
| 102 | Hypergammaglobulinemia (HP:0010702) | 1.98224947 |
| 103 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97724152 |
| 104 | IgA deficiency (HP:0002720) | 1.96358698 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 1.95778381 |
| 106 | Progressive muscle weakness (HP:0003323) | 1.93734810 |
| 107 | Abnormal tarsal ossification (HP:0008369) | 1.93081738 |
| 108 | Teleangiectasia of the skin (HP:0100585) | 1.92011593 |
| 109 | Impulsivity (HP:0100710) | 1.91546626 |
| 110 | Gout (HP:0001997) | 1.90685422 |
| 111 | Dysostosis multiplex (HP:0000943) | 1.90190429 |
| 112 | Degeneration of anterior horn cells (HP:0002398) | 1.87558884 |
| 113 | Abnormality of the anterior horn cell (HP:0006802) | 1.87558884 |
| 114 | Nasal polyposis (HP:0100582) | 1.87149311 |
| 115 | Villous atrophy (HP:0011473) | 1.86798261 |
| 116 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.86798261 |
| 117 | Muscle fiber atrophy (HP:0100295) | 1.86790678 |
| 118 | Recurrent skin infections (HP:0001581) | 1.86027342 |
| 119 | Xerostomia (HP:0000217) | 1.86026729 |
| 120 | Microvesicular hepatic steatosis (HP:0001414) | 1.85866113 |
| 121 | Breast hypoplasia (HP:0003187) | 1.85285889 |
| 122 | Urticaria (HP:0001025) | 1.84781556 |
| 123 | Overlapping toe (HP:0001845) | 1.84303395 |
| 124 | Encephalitis (HP:0002383) | 1.84095629 |
| 125 | Ureteral duplication (HP:0000073) | 1.83788082 |
| 126 | Abnormal trabecular bone morphology (HP:0100671) | 1.83583459 |
| 127 | Orchitis (HP:0100796) | 1.82244695 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81120656 |
| 129 | Obstructive lung disease (HP:0006536) | 1.81120656 |
| 130 | Spinal muscular atrophy (HP:0007269) | 1.80856553 |
| 131 | Thyroiditis (HP:0100646) | 1.80508843 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.80333200 |
| 133 | Facial hemangioma (HP:0000329) | 1.80070035 |
| 134 | Split foot (HP:0001839) | 1.79428060 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.79094547 |
| 136 | Prostate neoplasm (HP:0100787) | 1.78482041 |
| 137 | Abnormality of T cell number (HP:0011839) | 1.78422718 |
| 138 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.77078230 |
| 139 | Dicarboxylic aciduria (HP:0003215) | 1.76251288 |
| 140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76251288 |
| 141 | Increased CSF lactate (HP:0002490) | 1.75992559 |
| 142 | Cleft eyelid (HP:0000625) | 1.70574358 |
| 143 | Increased serum lactate (HP:0002151) | 1.70207347 |
| 144 | Abnormality of male internal genitalia (HP:0000022) | 1.68707124 |
| 145 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.68082211 |
| 146 | Lipid accumulation in hepatocytes (HP:0006561) | 1.68050297 |
| 147 | Chest pain (HP:0100749) | 1.67909940 |
| 148 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.67854903 |
| 149 | Poikiloderma (HP:0001029) | 1.67712070 |
| 150 | Hypochromic anemia (HP:0001931) | 1.67269809 |
| 151 | Hypertensive crisis (HP:0100735) | 1.65228808 |
| 152 | Alkalosis (HP:0001948) | 1.63506489 |
| 153 | Pulmonary fibrosis (HP:0002206) | 1.62639738 |
| 154 | Hepatitis (HP:0012115) | 1.62277760 |
| 155 | Amaurosis fugax (HP:0100576) | 1.60139074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 6.65329912 |
| 2 | ERN1 | 4.80109277 |
| 3 | TGFBR2 | 3.89152673 |
| 4 | IRAK3 | 3.43536141 |
| 5 | PRPF4B | 3.30047072 |
| 6 | BUB1 | 3.19988553 |
| 7 | TLK1 | 2.85761654 |
| 8 | MAP3K14 | 2.78410824 |
| 9 | TSSK6 | 2.76877889 |
| 10 | TBK1 | 2.68224995 |
| 11 | TYK2 | 2.63104718 |
| 12 | MAP3K10 | 2.42803021 |
| 13 | EIF2AK3 | 2.31686184 |
| 14 | ARAF | 2.25515501 |
| 15 | TAF1 | 2.21490440 |
| 16 | WEE1 | 2.16115710 |
| 17 | CSF1R | 2.10647025 |
| 18 | SMG1 | 2.00120275 |
| 19 | IKBKE | 1.92898032 |
| 20 | RIPK4 | 1.91158574 |
| 21 | NEK2 | 1.89740678 |
| 22 | VRK2 | 1.79773737 |
| 23 | IRAK4 | 1.75723409 |
| 24 | STK24 | 1.71392310 |
| 25 | PDK2 | 1.70170062 |
| 26 | NEK9 | 1.68357895 |
| 27 | EIF2AK2 | 1.67290388 |
| 28 | KIT | 1.56802404 |
| 29 | TAOK3 | 1.51867463 |
| 30 | GRK7 | 1.49891100 |
| 31 | IKBKB | 1.48289952 |
| 32 | BCKDK | 1.44902897 |
| 33 | FLT3 | 1.33245804 |
| 34 | PASK | 1.28559470 |
| 35 | MAP4K1 | 1.28242133 |
| 36 | PKN2 | 1.25469249 |
| 37 | MAP3K9 | 1.24015091 |
| 38 | EIF2AK1 | 1.20802105 |
| 39 | CCNB1 | 1.19805357 |
| 40 | MAP3K13 | 1.18703114 |
| 41 | MST4 | 1.16418987 |
| 42 | STK4 | 1.12451093 |
| 43 | LYN | 1.12134884 |
| 44 | CDK19 | 1.12007428 |
| 45 | SYK | 1.11303543 |
| 46 | PRKCQ | 1.11258343 |
| 47 | BLK | 1.09146801 |
| 48 | EPHA2 | 1.08399981 |
| 49 | CDC7 | 1.05908684 |
| 50 | NEK1 | 1.05222888 |
| 51 | SIK3 | 1.02347752 |
| 52 | MKNK1 | 1.01440252 |
| 53 | MKNK2 | 0.95803146 |
| 54 | PINK1 | 0.94754624 |
| 55 | DAPK3 | 0.93217833 |
| 56 | BMPR2 | 0.92622347 |
| 57 | MOS | 0.92253915 |
| 58 | CDK3 | 0.85519433 |
| 59 | PLK3 | 0.85102256 |
| 60 | TEC | 0.84074339 |
| 61 | ZAP70 | 0.84040492 |
| 62 | PLK4 | 0.83505791 |
| 63 | PRKCH | 0.81230573 |
| 64 | RPS6KA4 | 0.79625550 |
| 65 | STK16 | 0.79070998 |
| 66 | MAPK11 | 0.76117251 |
| 67 | MELK | 0.74326106 |
| 68 | CHEK2 | 0.71769200 |
| 69 | CHUK | 0.70209593 |
| 70 | BTK | 0.69487381 |
| 71 | STK38L | 0.67759917 |
| 72 | AKT3 | 0.65004417 |
| 73 | ITK | 0.64609411 |
| 74 | MAPK7 | 0.64191014 |
| 75 | PLK1 | 0.61526945 |
| 76 | PIM2 | 0.61260512 |
| 77 | JAK1 | 0.60017557 |
| 78 | AURKA | 0.57602396 |
| 79 | EEF2K | 0.56710816 |
| 80 | DYRK3 | 0.56606028 |
| 81 | TXK | 0.56379856 |
| 82 | PIK3CG | 0.55784619 |
| 83 | LCK | 0.55705994 |
| 84 | MARK3 | 0.55393118 |
| 85 | GRK5 | 0.55383359 |
| 86 | PDK1 | 0.55160713 |
| 87 | PIM1 | 0.53787030 |
| 88 | HCK | 0.53383386 |
| 89 | BRAF | 0.53178685 |
| 90 | FES | 0.50302948 |
| 91 | FGFR3 | 0.50270671 |
| 92 | BRSK2 | 0.49180500 |
| 93 | MAP3K6 | 0.48905565 |
| 94 | CDK4 | 0.48531323 |
| 95 | NUAK1 | 0.48526339 |
| 96 | JAK2 | 0.47708039 |
| 97 | JAK3 | 0.47618962 |
| 98 | MAP2K3 | 0.47607690 |
| 99 | ZAK | 0.45547632 |
| 100 | CAMKK2 | 0.45211421 |
| 101 | MAPK12 | 0.44996724 |
| 102 | SRPK1 | 0.44399957 |
| 103 | IRAK1 | 0.42083055 |
| 104 | MAPKAPK5 | 0.41464535 |
| 105 | ATR | 0.40912650 |
| 106 | MATK | 0.40662739 |
| 107 | VRK1 | 0.38527106 |
| 108 | LRRK2 | 0.37236644 |
| 109 | SCYL2 | 0.36883708 |
| 110 | CHEK1 | 0.36483170 |
| 111 | MAPK4 | 0.35649358 |
| 112 | DAPK1 | 0.34957340 |
| 113 | CAMKK1 | 0.34820378 |
| 114 | IRAK2 | 0.33703320 |
| 115 | AKT2 | 0.33525440 |
| 116 | PKN1 | 0.30674283 |
| 117 | SIK2 | 0.30362329 |
| 118 | EPHB1 | 0.30092960 |
| 119 | ALK | 0.28170021 |
| 120 | RAF1 | 0.28046911 |
| 121 | MAP3K8 | 0.27363479 |
| 122 | STK10 | 0.26653818 |
| 123 | RPS6KA5 | 0.26518936 |
| 124 | BRSK1 | 0.26330500 |
| 125 | ABL1 | 0.25666833 |
| 126 | NME1 | 0.25250495 |
| 127 | CDK7 | 0.24417785 |
| 128 | PRKCI | 0.22546500 |
| 129 | FGFR4 | 0.22155195 |
| 130 | PRKCD | 0.22055033 |
| 131 | CSNK2A1 | 0.21672822 |
| 132 | IGF1R | 0.21672230 |
| 133 | GRK6 | 0.21452999 |
| 134 | AURKB | 0.19830999 |
| 135 | RPS6KB2 | 0.19656647 |
| 136 | MAP2K6 | 0.15282203 |
| 137 | PAK4 | 0.14734007 |
| 138 | ADRBK2 | 0.14353713 |
| 139 | MAPK15 | 0.13688051 |
| 140 | PRKAA1 | 0.13479672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.50356289 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.96029558 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.90669474 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.44805073 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.43665670 |
| 6 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.32553027 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.05557285 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.90873852 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.90462962 |
| 10 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.75696045 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.73858730 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.65828679 |
| 13 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65569619 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.56006068 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55291876 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52182202 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47573628 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.46560011 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 2.38285117 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.26672067 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25200351 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01535421 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.89482101 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.83867785 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.63150015 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54686941 |
| 27 | Alcoholism_Homo sapiens_hsa05034 | 1.50327749 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42237731 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40978807 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.38204206 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29822086 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28522799 |
| 33 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.28436360 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27915542 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22508028 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21118330 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.15678844 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12024140 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06946364 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.05708170 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.02023294 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01266385 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 1.00944995 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00693772 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99366031 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97601037 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 0.95947009 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94711055 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93514193 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90864698 |
| 51 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88288913 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87969109 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.86837926 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.83977884 |
| 55 | Base excision repair_Homo sapiens_hsa03410 | 0.81924626 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.81797192 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.80857508 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76377644 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75544506 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 0.74217145 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 0.73661732 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69357890 |
| 63 | Measles_Homo sapiens_hsa05162 | 0.65584670 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.63702908 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62535244 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60498732 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56145906 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.55279206 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55102272 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55095282 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.54936506 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52394482 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51477267 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51368469 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51292885 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50378133 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49960044 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48675323 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.48122006 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46296592 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46103003 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44180496 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43664006 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.43593534 |
| 85 | Cell cycle_Homo sapiens_hsa04110 | 0.43256262 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39986213 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39705579 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39629116 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39401718 |
| 90 | Ribosome_Homo sapiens_hsa03010 | 0.39398987 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37706075 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37578034 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37399923 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36382497 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34982101 |
| 96 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34877183 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33878594 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32307052 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32004806 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31814065 |
| 101 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30799313 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30721446 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30685365 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30210197 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30209981 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29855017 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28313438 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27880035 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.26185435 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.24947577 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23088457 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.22862123 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22056548 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.18898964 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.17319157 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17237293 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17217597 |
| 118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.16940233 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.16899355 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.15907259 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14872318 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.14754736 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14675311 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.12258394 |
| 125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.11944276 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.11654070 |
| 127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.11487190 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10533204 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.10491069 |
| 130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.09105313 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.07928301 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.07401567 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.04726699 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.01810443 |

